IMMUNOHISTOCHEMICAL STUDY OF METALLOTHIONEIN IN NORMAL AND BENIGN PROSTATIC HYPERPLASIA OF HUMAN PROSTATE

被引:35
|
作者
SUZUKI, T
UMEYAMA, T
OHMA, C
YAMANAKA, H
SUZUKI, K
NAKAJIMA, K
KIMURA, M
机构
[1] GUNMA UNIV,DEPT PATHOL,MAEBASHI,GUNMA 371,JAPAN
[2] OTSUKA PHARMACEUT CO LTD,OTSUKA ASSAY LABS,TOKUSHIMA,JAPAN
[3] CENT INST EXPTL ANIM,KAWASAKI,JAPAN
来源
PROSTATE | 1991年 / 19卷 / 01期
关键词
IMMUNOHISTOCHEMISTRY; METALLOTHIONEIN; HUMAN PROSTATE;
D O I
10.1002/pros.2990190104
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Metallothionein (MT) in the human prostate gland was examined. Prostatic tissues were obtained from patients of urinary bladder cancer who had received radical cystoprostatectomy. MT content was 99.3-mu-g/g wet tissue (w.t.) in the peripheral zone (PZ), 12.0-mu-g/g w.t. in the preprostatic region (PR), 7.3-mu-g/g w.t. in the central zone (CZ), 6.8-mu-g/g w.t. in the anterior fibromuscular stroma, and 29.5-mu-g/g w.t. in benign nodular hyperplasia (adenoma) by radioimmunoassay. Immunohistochemical study demonstrated that MT was localized in the cytoplasm, nuclei of glandular epithelia, and secretory products. In general, a positive immunoreaction was strong in PZ and weak in CZ. It is considered that glandular epithelial cells in PZ, PR, CZ, and adenoma may react differently to heavy metals, e.g., zinc and cadmium.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 50 条
  • [41] PROLIFERATIVE RESPONSES OF CULTURED RAT PROSTATE AND HUMAN BENIGN PROSTATIC HYPERPLASIA
    MISTRY, D
    BUCHANAN, L
    DATTANI, G
    WEAVER, P
    RICHES, A
    PROSTATE, 1982, 3 (03): : 291 - 299
  • [42] EXPRESSION OF P53 IN THE BENIGN PROSTATIC HYPERPLASIA AND PROSTATE ADENOCARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY WITH CORRELATION TO PCNA EXPRESSION
    LEE, S
    RO, J
    PARK, K
    KWON, K
    AYALA, A
    LABORATORY INVESTIGATION, 1994, 70 (01) : A78 - A78
  • [43] Spatial architectures of somatic mutations in normal prostate, benign prostatic hyperplasia and coexisting prostate cancer
    Chae, Jeesoo
    Jung, Seung-Hyun
    Choi, Eun Ji
    Kim, Jae Woong
    Kim, Na Yung
    Moon, Sung Won
    Lee, Ji Youl
    Chung, Yeun-Jun
    Lee, Sug Hyung
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2024, 56 (01): : 168 - 176
  • [44] PROSTATE GROWTH-FACTOR - CHARACTERIZATION AND ITS ROLE IN NORMAL PROSTATE AND IN BENIGN PROSTATIC HYPERPLASIA
    STORY, MT
    AUTOCRINE AND PARACRINE MECHANISMS IN REPRODUCTIVE ENDOCRINOLOGY, 1989, : 29 - 48
  • [45] Spatial architectures of somatic mutations in normal prostate, benign prostatic hyperplasia and coexisting prostate cancer
    Jeesoo Chae
    Seung-Hyun Jung
    Eun Ji Choi
    Jae Woong Kim
    Na Yung Kim
    Sung Won Moon
    Ji Youl Lee
    Yeun-Jun Chung
    Sug Hyung Lee
    Experimental & Molecular Medicine, 2024, 56 : 168 - 176
  • [46] Benign prostatic hyperplasia. Prostate cancer
    Masson-Lecomte, A.
    PROGRES EN UROLOGIE, 2012, 22 (02): : F63 - F68
  • [47] Prostate development and growth in benign prostatic hyperplasia
    Timms, Barry G.
    Hofkamp, Luke E.
    DIFFERENTIATION, 2011, 82 (4-5) : 173 - 183
  • [48] Prostate Artery Embolization for Benign Prostatic Hyperplasia
    Mouli, Samdeep
    Salem, Riad
    Mcclure, Timothy D.
    JOURNAL OF UROLOGY, 2024, 212 (01): : 216 - 219
  • [49] THE ASSOCIATION OF BENIGN PROSTATIC HYPERPLASIA AND CANCER OF THE PROSTATE
    BOSTWICK, DG
    COONER, WH
    DENIS, L
    JONES, GW
    SCARDINO, PT
    MURPHY, GP
    CANCER, 1992, 70 (01) : 291 - 301
  • [50] Tuberculosis of the Prostate Presenting as Benign Prostatic Hyperplasia
    Fazarina, M.
    Tan, G. H.
    Badrulhisham, B.
    Shiran, M. S.
    Tan, G. C.
    MEDICINE AND HEALTH-KUALA LUMPUR, 2013, 8 (02): : 85 - 88